A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long-term mortality and morbidity
- 1 January 1987
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 9 (1), 197-203
- https://doi.org/10.1016/s0735-1097(87)80101-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsEuropean Heart Journal, 1985
- Follow-up after coronary arterial reperfusion with intravenous streptokinase in relation to residual myocardial infarct artery narrowingsThe American Journal of Cardiology, 1985
- Risk factors for sudden death after acute myocardial infarction: Two-year follow-upThe American Journal of Cardiology, 1984
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction.Circulation, 1982
- Thrombolytic TherapyNew England Journal of Medicine, 1982
- Percutaneous coronary angioplasty with and without prior streptokinase infusion for treatment of acute myocardial infarctionThe American Journal of Cardiology, 1982
- Thrombolytic therapy in myocardial infarctionProgress in Cardiovascular Diseases, 1979
- THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. II. CLINICAL OBSERVATIONS ON PATIENTS WITH MYOCARDIAL INFARCTION AND OTHER THROMBOEMBOLIC DISORDERS*†JCI Insight, 1959